Novo Nordisk (NVO) management said it’s not planning any more supply chain acquisitions in the wake of its deal to buy drug manufacturer Catalent (CTLT). Read more here.

As we invest in the future, we will permanently bring our medical supply chains back home. ... (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, ...

In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $81.79 as of Feb 12th. NVO’s trailing and forward P/E were 26.01 and 21.51 ...

Supply chain management has been under scrutiny these past few years as global-health, geopolitical and environmental crises have converged to wreak havoc on supply chains. The chip industry, in ...

Today, supply chains form the backbones of most economies and multinational companies – and they are in trouble. This report explores how supply chain fitness can help manage logistical challenges.